Arcturus Therapeutics Holdings Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 15.75M20.79M9.54M12.36M206.00M166.80M152.31M
Gross Profit 15.75M20.79M9.54M12.36M206.00M166.80M152.31M
Operating items
Research & Development 16.98M33.64M57.85M173.76M147.75M192.13M195.16M
Selling, General & Administrative 20.58M12.66M23.22M41.45M46.07M52.87M52.82M
Operating Expenses 37.56M46.30M81.06M215.21M193.82M245.00M247.98M
Operating Income -21.81M-25.51M-71.52M-202.85M12.18M-78.20M-95.67M
EBIT -21.81M-25.51M-71.52M-202.85M12.18M-78.20M-95.67M
Non-operating items
Other Non Operating Income 0.33M-0.45M-0.36M-1.92M-0.60M33.95M15.20M
Non Operating Income 0.33M-0.45M-0.36M-1.92M-0.42M16.59M15.20M
Net income details
EBT -21.81M-25.51M-71.52M-203.67M10.64M-27.89M-80.94M
Tax Provisions 1.29M1.83M-0.00M
Profit After Tax -21.79M-25.99M-72.15M-203.67M9.35M-29.73M-80.94M
Equity Income -0.30M-0.03M-0.26M0.52M-0.52M
Income from Continuing Operations -21.81M-25.51M-71.52M-203.67M9.35M-29.73M-80.94M
Consolidated Net Income -21.81M-25.51M-71.52M-203.67M9.35M-29.73M-80.94M
Income towards Parent Company -21.81M-25.51M-71.52M-203.67M9.35M-29.73M-80.94M
Net Income towards Common Stockholders -21.81M-25.51M-71.52M-203.67M9.35M-29.73M-80.94M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 10.70M15.14M24.49M26.36M26.49M26.72M27.09M
Shares Outstanding (Diluted Average) 26.32M27.09M26.63M27.00M
EBITDA -21.78M-25.99M-72.15M-203.67M9.35M-29.73M-80.94M
Tax Rate 12.17%0.00%